Literature DB >> 16585964

Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis.

Rajesh K Thimmulappa1, Hannah Lee, Tirumalai Rangasamy, Sekhar P Reddy, Masayuki Yamamoto, Thomas W Kensler, Shyam Biswal.   

Abstract

Host genetic factors that regulate innate immunity determine susceptibility to sepsis. Disruption of nuclear factor-erythroid 2-related factor 2 (Nrf2), a basic leucine zipper transcription factor that regulates redox balance and stress response, dramatically increased the mortality of mice in response to endotoxin- and cecal ligation and puncture-induced septic shock. LPS as well as TNF-alpha stimulus resulted in greater lung inflammation in Nrf2-deficient mice. Temporal analysis of pulmonary global gene expression after LPS challenge revealed augmented expression of large numbers of proinflammatory genes associated with the innate immune response at as early as 30 minutes in lungs of Nrf2-deficient mice, indicating severe immune dysregulation. The expression profile indicated that Nrf2 has a global influence on both MyD88-dependent and -independent signaling. Nrf2-deficient mouse embryonic fibroblasts showed greater activation of NF-kappaB and interferon regulatory factor 3 in response to LPS and polyinosinic-polycytidylic acid [poly(I:C)] stimulus, corroborating the effect of Nrf2 on MyD88-dependent and -independent signaling. Nrf2's regulation of cellular glutathione and other antioxidants is critical for optimal NF-kappaB activation in response to LPS and TNF-alpha. Our study reveals Nrf2 as a novel modifier gene of sepsis that determines survival by mounting an appropriate innate immune response.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16585964      PMCID: PMC1421348          DOI: 10.1172/JCI25790

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  44 in total

1.  Neutrophil recruitment and increased permeability during acute lung injury induced by lipopolysaccharide.

Authors:  M Chignard; V Balloy
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2000-12       Impact factor: 5.464

2.  Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care.

Authors:  D C Angus; W T Linde-Zwirble; J Lidicker; G Clermont; J Carcillo; M R Pinsky
Journal:  Crit Care Med       Date:  2001-07       Impact factor: 7.598

Review 3.  Genetic polymorphisms and sepsis.

Authors:  John Arcaroli; Michael B Fessler; Edward Abraham
Journal:  Shock       Date:  2005-10       Impact factor: 3.454

4.  Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice.

Authors:  M Ramos-Gomez; M K Kwak; P M Dolan; K Itoh; M Yamamoto; P Talalay; T W Kensler
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

5.  Lipopolysaccharide induces Rac1-dependent reactive oxygen species formation and coordinates tumor necrosis factor-alpha secretion through IKK regulation of NF-kappa B.

Authors:  S Sanlioglu; C M Williams; L Samavati; N S Butler; G Wang; P B McCray; T C Ritchie; G W Hunninghake; E Zandi; J F Engelhardt
Journal:  J Biol Chem       Date:  2001-06-11       Impact factor: 5.157

Review 6.  Recent advances towards understanding redox mechanisms in the activation of nuclear factor kappaB.

Authors:  Y M Janssen-Heininger; M E Poynter; P A Baeuerle
Journal:  Free Radic Biol Med       Date:  2000-05-01       Impact factor: 7.376

7.  Endotoxemia in transgenic mice overexpressing human glutathione peroxidases.

Authors:  O Mirochnitchenko; O Prokopenko; U Palnitkar; I Kister; W S Powell; M Inouye
Journal:  Circ Res       Date:  2000-08-18       Impact factor: 17.367

8.  Increased C5a receptor expression in sepsis.

Authors:  Niels C Riedemann; Ren-Feng Guo; Thomas A Neff; Ines J Laudes; Katie A Keller; Vidya J Sarma; Maciej M Markiewski; Dimitrios Mastellos; Christoph W Strey; Carl L Pierson; John D Lambris; Firas S Zetoune; Peter A Ward
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

9.  Acrolein causes transcriptional induction of phase II genes by activation of Nrf2 in human lung type II epithelial (A549) cells.

Authors:  R Tirumalai; T Rajesh Kumar; Kim Hue Mai; Shyam Biswal
Journal:  Toxicol Lett       Date:  2002-06-07       Impact factor: 4.372

10.  Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites.

Authors:  Peter Terness; Thomas M Bauer; Lars Röse; Christoph Dufter; Andrea Watzlik; Helmut Simon; Gerhard Opelz
Journal:  J Exp Med       Date:  2002-08-19       Impact factor: 14.307

View more
  394 in total

1.  Targeted deletion of nrf2 impairs lung development and oxidant injury in neonatal mice.

Authors:  Hye-Youn Cho; Bennett van Houten; Xuting Wang; Laura Miller-DeGraff; Jennifer Fostel; Wesley Gladwell; Ligon Perrow; Vijayalakshmi Panduri; Lester Kobzik; Masayuki Yamamoto; Douglas A Bell; Steven R Kleeberger
Journal:  Antioxid Redox Signal       Date:  2012-04-18       Impact factor: 8.401

2.  Emerging roles for multipotent, bone marrow-derived stromal cells in host defense.

Authors:  Jeffery J Auletta; Robert J Deans; Amelia M Bartholomew
Journal:  Blood       Date:  2012-01-06       Impact factor: 22.113

Review 3.  How does the macula protect itself from oxidative stress?

Authors:  James T Handa
Journal:  Mol Aspects Med       Date:  2012-04-05

4.  Nrf2 deficiency in myeloid cells is not sufficient to protect mice from high-fat diet-induced adipose tissue inflammation and insulin resistance.

Authors:  Akshaya K Meher; Poonam R Sharma; Vitor A Lira; Masayuki Yamamoto; Thomas W Kensler; Zhen Yan; Norbert Leitinger
Journal:  Free Radic Biol Med       Date:  2012-02-24       Impact factor: 7.376

5.  Depletion of Nrf2 enhances inflammation induced by oxyhemoglobin in cultured mice astrocytes.

Authors:  Hao Pan; Handong Wang; Lin Zhu; Lei Mao; Liang Qiao; Xingfen Su
Journal:  Neurochem Res       Date:  2011-08-11       Impact factor: 3.996

6.  Oxidative stress in sepsis: a redox redux.

Authors:  Jay K Kolls
Journal:  J Clin Invest       Date:  2006-04       Impact factor: 14.808

7.  Keap1 inhibition attenuates glomerulosclerosis.

Authors:  Yoichi Miyazaki; Akihiro Shimizu; Ira Pastan; Keiko Taguchi; Eriko Naganuma; Takafumi Suzuki; Tatsuo Hosoya; Takashi Yokoo; Akihiko Saito; Toshio Miyata; Masayuki Yamamoto; Taiji Matsusaka
Journal:  Nephrol Dial Transplant       Date:  2014-02-11       Impact factor: 5.992

8.  The Nrf2 activator tBHQ inhibits T cell activation of primary human CD4 T cells.

Authors:  Alexandra E Turley; Joseph W Zagorski; Cheryl E Rockwell
Journal:  Cytokine       Date:  2014-12-05       Impact factor: 3.861

Review 9.  Regenerative stromal cell therapy in allogeneic hematopoietic stem cell transplantation: current impact and future directions.

Authors:  Jeffery J Auletta; Kenneth R Cooke; Luis A Solchaga; Robert J Deans; Wouter van't Hof
Journal:  Biol Blood Marrow Transplant       Date:  2009-12-16       Impact factor: 5.742

10.  Proteomic analysis of brain protein expression levels in NF-kappabeta p50 -/- homozygous knockout mice.

Authors:  Joshua B Owen; Wycliffe O Opii; Charles Ramassamy; William M Pierce; D Allan Butterfield
Journal:  Brain Res       Date:  2008-09-12       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.